Online-Trading Portfolio-Tracker Research Back-Office MF-Tracker
BSE Prices delayed by 5 minutes... << Prices as on May 03, 2024 >>   ABB 6698.75 [ 0.29 ]ACC 2534.15 [ 0.25 ]AMBUJA CEM 622.25 [ -0.50 ]ASIAN PAINTS 2927.5 [ -1.56 ]AXIS BANK 1141.05 [ -0.76 ]BAJAJ AUTO 9098.75 [ -0.06 ]BANKOFBARODA 276 [ -1.18 ]BHARTI AIRTE 1276.75 [ -2.25 ]BHEL 305.1 [ 4.25 ]BPCL 629.8 [ -0.79 ]BRITANIAINDS 4745.15 [ -0.32 ]CIPLA 1424.75 [ 0.37 ]COAL INDIA 474.8 [ 4.75 ]COLGATEPALMO 2793.65 [ -0.63 ]DABUR INDIA 531.25 [ 1.33 ]DLF 878.05 [ -1.98 ]DRREDDYSLAB 6349.95 [ 0.98 ]GAIL 203.8 [ -0.59 ]GRASIM INDS 2482.4 [ 1.98 ]HCLTECHNOLOG 1347.8 [ -0.93 ]HDFC 2729.95 [ -0.62 ]HDFC BANK 1518.65 [ -0.94 ]HEROMOTOCORP 4546.9 [ -0.34 ]HIND.UNILEV 2215.5 [ -0.45 ]HINDALCO 647.05 [ 0.88 ]ICICI BANK 1142 [ 0.18 ]IDFC 119.4 [ -1.61 ]INDIANHOTELS 570.9 [ -0.88 ]INDUSINDBANK 1482.7 [ -1.53 ]INFOSYS 1416.45 [ 0.11 ]ITC LTD 436.25 [ -0.65 ]JINDALSTLPOW 931.6 [ -1.09 ]KOTAK BANK 1547.25 [ -1.81 ]L&T 3499.1 [ -2.74 ]LUPIN 1655.25 [ 0.46 ]MAH&MAH 2192.95 [ 0.39 ]MARUTI SUZUK 12491.15 [ -2.37 ]MTNL 38.05 [ 0.03 ]NESTLE 2455.6 [ -2.22 ]NIIT 104.45 [ -0.76 ]NMDC 269.1 [ 4.12 ]NTPC 365.1 [ -1.15 ]ONGC 286 [ 1.19 ]PNB 135.8 [ -1.59 ]POWER GRID 310.7 [ -0.88 ]RIL 2868.5 [ -2.17 ]SBI 831.55 [ 0.18 ]SESA GOA 415.15 [ 1.08 ]SHIPPINGCORP 221.5 [ -2.66 ]SUNPHRMINDS 1508.4 [ -0.66 ]TATA CHEM 1090.7 [ -0.91 ]TATA GLOBAL 1093.95 [ 0.26 ]TATA MOTORS 1013.8 [ -1.38 ]TATA STEEL 166.45 [ -0.54 ]TATAPOWERCOM 454.6 [ -0.68 ]TCS 3839.35 [ -0.63 ]TECH MAHINDR 1249.65 [ -1.36 ]ULTRATECHCEM 9816.75 [ -1.65 ]UNITED SPIRI 1208.2 [ 1.16 ]WIPRO 456.85 [ -0.09 ]ZEETELEFILMS 143.05 [ -0.59 ] BSE NSE
You can view the entire text of Notes to accounts of the company for the latest year

BSE: 500940ISIN: INE183A01024INDUSTRY: Plastics - Pipes & Fittings

BSE   ` 270.90   Open: 270.70   Today's Range 267.25
277.00
+2.40 (+ 0.89 %) Prev Close: 268.50 52 Week Range 163.00
279.50
Year End :2023-03 

i) The Company has not made any bonus issue or issue of equity shares pursuant to contracts without payment received in cash or bought back any shares for the period of five years immediately preceding the balance sheet date.

ii) The Company has only one class of equity shares having a par value of ^ 2/- each. Each equity shareholder is entitled to one vote per share and has a right to receive dividend as recommended by Board of Directors subject to the necessary approval from the shareholders.

In the event of liquidation of the Company, the holders of equity shares will be entitled to receive remaining assets of the Company, after distribution of all preferential amounts. The distribution will be in proportion to the number of equity shares held by the shareholders.

iii) The Board of Directors have proposed on May 22, 2023, a final dividend of ^ 1.50/- (75%) per equity share for financial year 2022-23. The same is subject to approval of the shareholders of the Company at the annual general meeting for the year ended March 31, 2023.

Nature and purpose of reserves

1. Capital redemption reserve

Capital redemption reserve is being created by transfer from Retained earnings at the time of buy back of equity shares in accordance with the Act. The reserve will be utilised in accordance with the provisions of the Act.

2. General reserve

General reserve is created from time to time by way of transfer of profits from retained earnings for appropriation purposes. General reserve is created by a transfer from one component of equity to another and is not an item of other comprehensive income.

3. Securities premium

Amount received (on issue of shares) in excess of the par value has been classified as securities premium. The reserve is utilised in accordance with the provisions of the Companies Act.

4. Retained earnings

Retained earnings are the profits that the Company has earned till date, less any transfers to general reserve, dividends or other distributions paid to shareholders.

5. Equity instruments through other comprehensive income

Equity instruments through other comprehensive income represents unrealised fair value gain(or) loss in investments valued at FVOCI.

Details of terms of borrowings and security for the borrowings

Buyer's credits are part of working capital facilities. These are repayable based on the terms of each buyer's credit which is upto 90 days. The interest rate ranging from 0.60% to 5.21%.

Cash credits facilities have interest rate ranging from 6.60% to 9.60%.

The Company has aggregate limits of working capital borrowings of ' 1,916.25 crores

(March 31, 2022: ' 1,606 crores) from various banks.

Borrowings from banks have been utilized for the purpose for which it were taken.

24 Income-taxes

The note below details the major components of income-tax expenses for the year ended March 31, 2023 and March 31, 2022. The note further describes the significant estimates made in relation to Company's income tax position, and also explains how the income tax expense is impacted by non-assessable and non-deductible items.

D Composition of deferred tax assets and deferred tax liabilities

Deferred taxes are measured using the tax rates that have been enacted or substantively enacted by the end of the reporting period. The Company offsets tax assets and liabilities if and only if it has a legally enforceable right to set off current tax assets and current tax liabilities and the deferred tax assets and deferred tax liabilities relate to income taxes levied by the same tax authority.

Disclosures pursuant to Ind AS 115 - Revenue from contract with customers, are as follows:

(a) Revenue streams

The Company derives revenue form sale of Pipes and fittings and PVC resin, which is disclosed in note no. 34 as segment revenue. Hence, no disaggregation of revenue is provided separately.

(b) Disaggregation of revenue from contracts with customers

The Company has performed a disaggregated analysis of revenues considering the nature, amount, timing and uncertainty of revenues. This includes disclosure of revenues by product lines, timing of revenue recognition and geography:

Nature of CSR activities:

Agriculture and rural development, eradicating hunger and poverty, promoting education, vocational skills, and livelihood, gender equality and women empowerment, preventive healthcare, heritage art and culture, environmental sustainability, promoting sports, sanitation, hygiene and safe drinking water, animal welfare, support to differently abled, technology incubators, armed forces/veterans, contribution to Swachh Bharat Kosh Clean Ganga Fund.

Consequent to the approval of the Board of Directors at their meeting held on September 15, 2021, the Company transferred leasehold rights of approx. 34.88 acres of land (out of approx. 70 acres) during the quarter post completion of necessary regulatory approvals and formalities. The Company has accordingly, recognised ^ 376.06 crores net gain, disclosed as exceptional item during the previous year.

34 Segment information

The Company is in the business of manufacturing PVC resin and PVC pipes & fittings and based on the management approach as defined in Ind AS 108, the Chief operating Decision Maker (CODM) monitors and review the operating results of the Company in these two segments.. Therefore as per Ind AS 108 "Operating Segments", the Company has disclosed two segments i.e. PVC resin and PVC pipes & fittings.

The management monitors the operating results of its business units separately for the purpose of making decisions about resource allocation and performance assessment. Segment performance is evaluated based on profit or loss that is measured consistently with profit or loss in the financial statements. The Company's financing (including finance costs and finance income) and income taxes are not allocated to operating segments.

Inter-segment revenues are eliminated upon consolidation and reflected in the 'adjustments and eliminations' column. All other adjustments and eliminations are part of detailed reconciliations presented further below.

Adjustments and eliminations

Finance income/costs and fair value gains and losses on financial assets are not allocated to individual segments as the underlying instruments are managed for the entity as a whole.

Current taxes, deferred taxes and certain financial assets and liabilities are not allocated to these segments as they are managed for the entity as a whole.

Capital expenditure consists of additions of property, plant and equipment and intangible assets and additions to capital work-in-progress.

Inter-segment revenues are eliminated on consolidation.

35 Earnings per share (EPS)

Basic EPS is calculated by dividing the profit for the year attributable to equity holders by the weighted average number of Equity shares outstanding during the year. In compliance with Indian Accounting Standard 33 - 'Earnings per share'.

There are no potential shares that have a dilutive effect on the EPS.

36 Disclosure pursuant to employee benefits

A. Defined contribution plans:

Amount of ^ 6.87 crores (March 31, 2022: ^ 6.11 crores) is recognised as expenses and included in note no. 29 "Employee benefits expense".

The contribution are made to recognised provident fund administered by the Government of India for employees @12% of basic salary per regulation. The obligation of the Company is limited to the amount contributed and it has no further contractual constructive obligation.

B. Defined benefit plans:

The Company has Gratuity as post employment benefit which is in the nature of defined benefit plan.

The Company operates gratuity plan (funded) wherein every employee is entitled to the benefit equivalent to fifteen days salary last drawn for each completed year of service as per Payment of Gratuity Act, 1972. The same is payable on termination of service or retirement whichever is earlier. The benefit vests after five years of continuous service.

The sensitivity analysis above has been determined based on a method that extrapolates the impact on the defined benefit obligation as a result of reasonable changes in key assumptions occurring at the end of the reporting period. The sensitivity analysis is based on a change in one significant assumption at a time, keeping all other assumptions constant. The sensitivity analysis may not be representative of an actual change in the defined benefit obligation as it is unlikely that changes in assumptions would occur in isolation of one another.

The same method has been applied for the sensitivity analysis when calculating the recognised defined benefit obligation.

Risk exposure and asset liability matching

Provision of a defined benefit scheme poses certain risks, some of which are detailed hereunder, as companies take on uncertain long term obligations to make future benefit payments.

1. Liability risks

a. Asset-liability mismatch risk

Risk which arises if there is a mismatch in the duration of the assets relative to the liabilities. By matching duration with the defined benefit liabilities, the Company is successfully able to neutralize valuation swings caused by interest rate movements. Hence companies are encouraged to adopt asset-liability management.

b. Discount rate risk

Variations in the discount rate used to compute the present value of the liabilities may seem small, but in practice can have a significant impact on the defined benefit liabilities.

c. Future salary escalation and inflation risk

Since price inflation and salary growth are linked economically, they are combined for disclosure purposes. Rising salaries will often result in higher future defined benefit payments resulting in a higher present value of liabilities especially unexpected salary increases provided at management's discretion may lead to uncertainties in estimating this increasing risk.

d. Withdrawal

Actual withdrawal providing higher or lower than assumed withdrawal and change of withdrawal rate at subsequent valuation can impact plan's liability.

2. Asset risks

All plan assets are maintained in a trust fund managed by a public sector insurer viz; LIC of India. LIC has a sovereign guarantee and has been providing consistent and competitive returns over the years. The Company has opted for a traditional fund wherein all assets are invested primarily in risk averse markets. The Company has no control over the management of funds but this option provides a high level of safety for the total corpus. A single account is maintained for both the investment and claim settlement and hence 100% liquidity is ensured. Also interest rate and inflation risk are taken care of.

37 Related party transactions

In accordance with the requirement of Ind AS 24 'Related Party Disclosures', name of related parties, their relationships, transactions and outstanding balances with them as identified and certified by the management are as follows:

A. Names of the related party and nature of relationship where control exists

There are no parties where control exists.

Terms and conditions of transactions with related parties

Transaction entered into with related parties are made in ordinary course of business and on terms equivalent to those that prevail in arm's length transactions. Outstanding balances at the year-end are unsecured and interest free and settlement occurs in cash. There have been no guarantees provided or received for any related party receivables or payables.

38 Commitments and contingencies

38.1 Commitments

a) Capital commitments :

Estimated amount of contracts remaining to be executed on capital account and not provided for as at March 31, 2023'71.39 crores (March 31, 2022: ' 49.50 crores)

b) Other commitments :

Aggregate amount of bank guarantees other than the performance guarantees outstanding as on March 31, 2023 is ' 34.40 crores (March 31, 2022: ' 31.09 Crores)

38.2 Contingent liabilities

Particulars

March 31, 2023

March 31, 2022

Claims against the Company not acknowledged as debt in respect of:

a)

Income-tax matters

13.01

3.98

b)

Excise/ Customs/ Service tax matters

61.17

70.55

c)

Sales tax matters

2.11

2.11

d)

Consumer protection matters

0.24

0.07

39 Fair value of financial assets and liabilities

This note explains the judgements and estimates made in determining the fair values of the financial instruments that are recognised and measured at (i) fair value (ii) measured at amortised cost and for which fair values are considered to be same as the amortised costs disclosed in the financial statements. They are further classified them into Level 1 to Level 3 as required by the accounting standard and described in the significant accounting policies of the Company. Further, the note describes valuation techniques used, key inputs to valuations and quantitative information about significant unobservable inputs for fair value measurements.

Valuation techniques used to determine the fair value of each financial instrument:

Fair value of financial instruments classified at amortised cost:

The management assessed that the fair values of cash and bank, loans, trade receivables, accrued interest, borrowings, trade payables and other financial liabilities approximate their carrying amounts largely due to the short-term maturities of these instruments.

Carrying value of non-current financial liabilities are considered to be same as their fair value due to discounting at rate which are an approximation of incremental borrowing rate.

Fair value of financial instruments classified at FVTPL:

These financial instruments consist of investment in quoted equity instruments and units of mutual funds. The fair value of quoted equity instruments is based on the respective quoted price in the active markets as at the measurement date and fair value of investment in mutual funds is determined using the quoted price ( NAV ) of the respective units in the active market at the measurement date.

Fair value of financial instruments classified at FVTOCI:

These financial instruments consist of investment in equity instruments. The fair value of quoted equity instruments is based on the respective quoted price in the active markets as at the measurement date. The fair value of investments in unquoted equity shares has been estimated using the net asset method. The valuation requires to consider the cost of replacement of an asset as an indication of the fair market value of that asset.

During the year ended March 31, 2023 and March 31, 2022, there were no transfers between Level 1 and Level 2 fair value measurements.

The Company maintains policies and procedures to value financial assets or financial liabilities using the best and most relevant data available. In addition, the Company internally reviews valuations, including independent price validation for certain instruments.

The Company is exposed to market risk, credit risk and liquidity risk. The Company's management oversees the management of these risks. The Company's management is supported by a risk management committee that advises on financial risks and the appropriate financial risk governance framework. The risk management committee provides assurance to the Company's management that the Company's financial risk activities are governed by appropriate policies and procedures and that financial risks are identified, measured and managed in accordance with Company's policies appetite. It is the Company's policy that no trading in derivatives for speculative purposes may be undertaken. The Board of Directors reviews and agrees policies for managing each of these risks, which are summarised below.

i) Credit risk

Credit risk is the risk that counterparty will not meet its obligations under a financial instrument or customer contract, leading to a financial loss. The Company evaluates credit risk with respect to trade receivables as significantly low, as its payment terms are mostly advance basis.

a) Trade receivables

In respect of trade receivables, the Company is not exposed to any significant credit risk exposure to any single counter party or any group of counter parties having similar characteristics. Trade receivables consist of a large number of customers. The Company has very limited history of customer default, and considers the credit quality of trade receivables that are not past due or impaired to be good.

ii) Liquidity risk

Liquidity risk is the risk that the Company may not be able to meet its present and future cash flow and collateral obligations without incurring unacceptable losses. The Company's objective is to, at all time maintain optimum levels of liquidity to meet its cash and collateral requirements. The Company closely monitors its liquidity position and deploys a robust cash management system.

The Company manages liquidity risk by maintaining adequate reserves, banking facilities and committed borrowing facilities, by continuously monitoring forecast and actual cash flows, and by matching the maturity profiles of financial assets and liabilities and by monitoring rolling forecasts of its liquidity requirements to ensure it has sufficient cash to meet operational needs while maintaining sufficient headroom on its undrawn committed borrowing facilities at all times so that the Company does not breach borrowing limits or covenants (where applicable) on any of its borrowing facilities.

The table summarises the maturity profile of Company's financial liabilities based on contractual undiscounted payments.

iii) Market risk

Market risk is the risk that the fair value of future cash flows of a financial instrument will fluctuate because of changes in market prices. Market risk comprises three types of risk interest rate risk, currency risk and other price risk such as equity price risk and commodity risk. Financial instruments affected by market risk include borrowings, trade and other payables, trade receivables, investments, other financial liabilities.

The sensitivity analysis in the following sections relate to the position as at March 31, 2023 and March 31, 2022. The sensitivity of the relevant income statement item is the effect of the assumed changes in respective market risks. The sensitivity analyses have been prepared on the basis that the amount of net debt, the ratio of fixed to floating interest rates of the debt, proportion of financial instruments in foreign currencies are all constant at March 31, 2023.

The analyses exclude the impact of movements in market variables on: the carrying values of gratuity, other post retirement obligations and provisions Company's activities expose it to variety of financial risks, including effect of changes in foreign currency exchange rate and interest rate.

a) Foreign currency risk

Foreign currency risk is the risk that the future cash flows of a financial instrument will fluctuate because of changes in foreign exchange rates.

The Company's exposure to the risk of changes in foreign exchange rates relates primarily to its operating activities on account of import of raw materials.

PVC pricing is on import parity and import parity value of sales of the Company exceeds the USD payables on a six monthly rolling basis and hence the Company does not generally need to resort to hedging by way of forward contracts, options, etc.

b) Interest rate risk

Interest rate risk is the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in market interest rates.

The Company has short term borrowings with fixed interest rates and hence the future cash-flows of relevant financial instrument are not affected by changes in market interest rate.

c) Price risk

i) Commodity price risk

The Company is affected by the volatility of prices of certain commodity chemicals (Ethylene and PVC) and intermediates (Ethylene and Ethylene Dichloride ('EDC') and Vinyl Chloride Monomer ('VCM')). Its operating activities involve the ongoing purchase of VCM, EDC, all being petrochemical products for manufacturing of PVC and pipes and fittings and therefore require a continuous supply of these materials. Prices of PVC manufactured by the Company are monitored by the Company's management and are adjusted to respond to change in import parity price of PVC in Indian market. Market price of input and output, generally get adjusted over a period of time. Accordingly, the Company is exposed to the variation in prices over short term period.

ii) Equity price risk

The Company's listed and unlisted equity securities are susceptible to market-price risk arising from uncertainties about future values of the investment securities. The equity securities held by the Company are strategic in nature. The Company's Board of Directors reviews and approves all equity investment decisions.

At the reporting date, the exposure to unlisted equity securities at fair value was ' 12.38 crores . A decrease of 10% in the fair value will have an impact of approximately ' 1.24 crores on OCI. An increase of 10% in the value of the securities would also impact OCI.

At the reporting date, the exposure to listed equity securities at fair value was ' 1803.52 crores. A decrease of 10% on the NSE market index could have an impact of approximately ' 180.29 crores on OCI and ' 0.06 crores on Profit and loss or equity attributable to the Company. An increase of 10% in the value of the listed securities would also impact OCI, profit and loss and equity.

41 Capital management

Capital includes equity shares and other equity attributable to the equity holders of the Company. The primary objective of the Company's capital management is to ensure its ability to continue as going concern, maintain a strong credit rating and healthy capital ratios in order to support its business and maximise shareholder value. The Company is not subject to externally imposed capital requirement. The Company manages its capital structure and makes adjustments to maintain efficient financing structure in light of changes in economic conditions. To maintain or adjust the capital structure, the Company may adjust the dividend payment to shareholders, return capital to shareholders or issue new shares. Company monitors capital using a gearing ratio, which is total debt divided by total capital plus other equity.

42 Details of dues to Micro and Small Enterprises as defined under MSMED Act, 2006 (as amended)

The management has identified enterprises which qualify under the definition of micro enterprises and small enterprises, as defined under Micro, Small and Medium Enterprises Development (MSMED) Act, 2006. Accordingly, the disclosure in respect of the amounts payable to such enterprises as at the year end has been made in the standalone financial statements based on information received and available with the Company and has been relied upon by the statutory auditor.

44 Disclosure pursuant to Ind AS 116

(a) The Company as a lessee has obtained certain assets such as immovable properties on leasing arrangements for the purposes of its fitting unit. With the exception of short-term leases and leases of low value underlying assets, each lease is reflected on the balance sheet as a right-to-use asset and a lease liability. Variable lease payment which do not depend on an index or a rate are excluded from the initial measurement of the lease liability and right-of-use assets. The Company has presented its right-of-use assets separately from other assets. Each lease generally imposes a restriction that unless there is a contractual right for the Company to sub-lease the asset to another party, the right-of-use asset can only be used by the Company. Some lease contain an option to extend the lease for a further term.

(b) Additional information on extension/ termination options: Extension and termination options are included in a number of property lease arrangements of the Company. These are used to maximise operational flexibility in terms of managing the assets used in the Company's operations. The majority of extension and termination options held are exercisable based on consent of the Company.

(c) There are no leases which are yet to commence as on March 31, 2023.

(d) Lease payments, not included in measurement of liability

45 Utilization of borrowed funds

(i) No funds have been advanced or loaned or invested (either from borrowed funds or share premium or any other sources or kind of funds) by the Company to or in any other person(s) or entity(ies), including foreign entities (“Intermediaries”), with the understanding, whether recorded in writing or otherwise, that the Intermediary shall, whether, directly or indirectly lend or invest in other persons or entities identified in any manner whatsoever by or on behalf of the Company (“Ultimate Beneficiaries”) or provide any guarantee, security or the like on behalf of the Ultimate Beneficiaries.

(ii) No funds have been received by the Company from any person(s) or entity(ies), including foreign entities (“Funding Parties”), with the understanding, whether recorded in writing or otherwise, that the Company shall, whether, directly or indirectly, lend or invest in other persons or entities identified in any manner whatsoever by or on behalf of the Funding Party (“Ultimate Beneficiaries”) or provide any guarantee, security or the like on behalf of the Ultimate Beneficiaries.

46 Undisclosed income :

There are no transactions that have not been recorded in the books of accounts and has been surrendered or

disclosed as income during the year in the tax assessments under the Income-tax Act, 1961

47 Details of Crypto Currency or Virtual currency :

The Company has not traded or invested in crypto currency or virtual currency during the year.

48 Transactions with struck-off companies :

The Company does not have any transaction or outstanding balance with struck-off companies under section 248 of the Companies Act, 2013 or section 560 of Companies Act, 1956, during current and previous year.

49 Registration/satisfaction of charges with Registrar :

There are no charges or satisfaction which is yet to be registered with Registrar of Companies beyond the statutory period in the current as well as in the previous year.

50 Previous year comparatives

Previous year's figures have been regrouped/ reclassified wherever necessary to correspond with the current year's classification / disclosure.

The accompanying notes to the standalone financial statements including a summary of significant accounting policies and explanatory information form an integral part of these standalone financial statements.